The human immunodeficiency virus type 1 Nef and Vpu proteins downregulate the natural killer cell-activating ligand PVR.
about
Recognition and Regulation of T Cells by NK CellsHIV Genome-Wide Protein Associations: a Review of 30 Years of ResearchViral Evasion of Natural Killer Cell ActivationRemodeling of the Host Cell Plasma Membrane by HIV-1 Nef and Vpu: A Strategy to Ensure Viral Fitness and PersistenceVpu Protein: The Viroporin Encoded by HIV-1Natural killer cells and neuroblastoma: tumor recognition, escape mechanisms, and possible novel immunotherapeutic approachesInsufficient natural killer cell responses against retroviruses: how to improve NK cell killing of retrovirus-infected cellsCell Surface Proteomic Map of HIV Infection Reveals Antagonism of Amino Acid Metabolism by Vpu and Nef.Recognition of nectin-2 by the natural killer cell receptor T cell immunoglobulin and ITIM domain (TIGIT).DNAM-1 control of natural killer cells functions through nectin and nectin-like proteins.HIV-1 Vpu antagonism of tetherin inhibits antibody-dependent cellular cytotoxic responses by natural killer cells.Balancing natural killer cell activation through paired receptors.Modulation of CD112 by the alphaherpesvirus gD protein suppresses DNAM-1-dependent NK cell-mediated lysis of infected cells.HIV-1 infection causes a down-regulation of genes involved in ribosome biogenesisHIV-1 Vpu accessory protein induces caspase-mediated cleavage of IRF3 transcription factorInvolvement of a C-terminal motif in the interference of primate lentiviral Vpu proteins with CD1d-mediated antigen presentation.HIV-1 Vpu utilizes both cullin-RING ligase (CRL) dependent and independent mechanisms to downmodulate host proteins.Human NK cell repertoire diversity reflects immune experience and correlates with viral susceptibility.HIV-1 Vpu interference with innate cell-mediated immune mechanisms.Natural Killer Cell Memory.Roles of natural killer cells in antiviral immunityImpaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulationHIV-1 Vpu Mediates HLA-C Downregulation.Natural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 stimulationThe Antagonism of HIV-1 Nef to SERINC5 Particle Infectivity Restriction Involves the Counteraction of Virion-Associated Pools of the Restriction Factor.Preservation of tetherin and CD4 counter-activities in circulating Vpu alleles despite extensive sequence variation within HIV-1 infected individuals.Perturbed CD8+ T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals.The DNA Damage Response: A Common Pathway in the Regulation of NKG2D and DNAM-1 Ligand Expression in Normal, Infected, and Cancer Cells.Baseline and Dynamic Expression of Activating NK Cell Receptors in the Control of Chronic Viral Infections: The Paradigm of HIV-1 and HCV.The human immunodeficiency virus type 1 Vpr protein upregulates PVR via activation of the ATR-mediated DNA damage response pathway.Critical roles of co-activation receptor DNAX accessory molecule-1 in natural killer cell immunity.Validation of an Immunohistochemistry Assay for Detection of CD155, the Poliovirus Receptor, in Malignant Gliomas.HIV-1 Vpu Downmodulates ICAM-1 Expression, Resulting in Decreased Killing of Infected CD4+ T Cells by NK CellsImpaired Downregulation of NKG2D Ligands by Nef Proteins from Elite Controllers Sensitizes HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity.In vitro functional assessment of natural HIV-1 group M Vpu sequences using a universal priming approach.HIV-1 adaptation to NK cell-mediated immune pressure.DNAM-1 controls NK cell activation via an ITT-like motif.Viral inhibitors of NKG2D ligands for tumor surveillance.Conserved residues within the HIV-1 Vpu transmembrane-proximal hinge region modulate BST2 binding and antagonism.HIV-1 Nef and Vpu are functionally redundant broad-spectrum modulators of cell surface receptors, including tetraspanins.
P2860
Q26742166-91518DD6-B82F-4F3F-8EEB-1EF220BF7FFAQ26746070-BE2F4B89-3F52-4FA4-BF87-4EE07E28EB4EQ26748421-4EE2E27A-0775-41D4-8B45-8AC11614F31BQ26767362-040CCC64-81D4-4935-9679-832C4CE5F9D4Q26801489-DCB56864-927B-4022-B7AF-38DFE7B8CD98Q26825652-0361EA67-EE67-41B2-BBBC-6EBD7FB7442BQ28068375-7E84883A-3A4F-4582-9180-926C01BF0D4AQ30379978-53D8ACCB-A45B-45D5-85AC-D0A55C914EF6Q30402088-2EE46CF6-DBBC-44E5-B582-5C1374C25C5DQ30716850-EB70DD78-2556-4292-B8D9-803C7E345620Q33887674-E2B9AD2A-75DD-4739-A2A5-826F969DED1EQ34465877-5A6303AF-96D0-4406-BD99-9AE250136C4AQ34526520-94520C79-93E8-4C2F-B2BB-94D8520C00DDQ34612239-D2642895-612B-4DEA-97E5-A98C7737C86FQ34737736-923BDECF-3466-44FC-A97E-402EC6B28F00Q35424048-EA2A831A-2A3F-4D3F-B126-503BA431CAFDQ35895988-507D1D36-02EC-4445-BA74-466B8E6E5A7DQ35990726-0AB0B98F-11C0-4071-ADEA-0527402F926FQ36141355-64D92B46-F1BE-499E-B618-2D409ED4592AQ36211144-F82883CA-2DBB-4E10-85CA-C4E698A6CA5EQ36767761-1832B047-D324-411A-9BBC-41E3BA1C1D39Q36957280-8E4C4298-4E5E-4FD2-BC4A-CAD9688044CFQ36997294-A8C54FB6-CA29-4D94-AEBC-09CA68401BFBQ37031810-B25E7003-9340-4064-8660-F81D0A66E8FEQ37415400-4976646F-38BE-4BED-8AD4-48EB8CF1F456Q37510562-7FA20911-ED1D-4EB5-A7DE-B3A90727AB83Q37584487-89C6AB08-0385-452B-ABAB-5F2301F97890Q38178966-17271F14-B80A-4333-946C-5FB232AB52E7Q38234942-4A26CF26-09F4-40B0-BEB5-918B9E265B7EQ38281980-91213F28-21AB-4B52-AEC8-6469BB49638FQ38559350-1359AC78-A1D2-4A4F-8AC2-9FCF9171A22CQ38614523-86A18840-0492-42E2-BEA0-FABE037E8EEFQ38718438-995EA375-0441-49F7-BA95-904BBB9F8E98Q38725490-C09F3D1A-2EC0-40A1-AB35-53AE13FA738DQ38730130-4E459DE2-248A-4E37-B80C-E859BD4647DFQ38743267-8C083028-E3F7-45D3-A7B1-F3DCD1552161Q38820709-88E6A33F-200E-4C44-A230-24849AB542E0Q38870478-C2523A18-2C9E-41C6-B160-1DF47F4F8B30Q38910738-E363388C-FBBC-4A0A-A6E6-D90A8A54A860Q38951336-DE5CB1AF-38C4-4459-8FB0-2F94E9F17E2A
P2860
The human immunodeficiency virus type 1 Nef and Vpu proteins downregulate the natural killer cell-activating ligand PVR.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The human immunodeficiency vir ...... er cell-activating ligand PVR.
@en
The human immunodeficiency vir ...... er cell-activating ligand PVR.
@nl
type
label
The human immunodeficiency vir ...... er cell-activating ligand PVR.
@en
The human immunodeficiency vir ...... er cell-activating ligand PVR.
@nl
prefLabel
The human immunodeficiency vir ...... er cell-activating ligand PVR.
@en
The human immunodeficiency vir ...... er cell-activating ligand PVR.
@nl
P2093
P2860
P356
P1433
P1476
The human immunodeficiency vir ...... er cell-activating ligand PVR.
@en
P2093
Angela Santoni
Cristina Cerboni
Marina Potestà
P2860
P304
P356
10.1128/JVI.05788-11
P407
P577
2012-02-01T00:00:00Z